MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

StemCells Company Profile (NASDAQ:STEM)

Consensus Ratings for StemCells (NASDAQ:STEM) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.50 (477.50% upside)

Analysts' Ratings History for StemCells (NASDAQ:STEM)
Show:
DateFirmActionRatingPrice TargetActions
5/11/2016S&P Equity ResearchLower Price Target$3.59 -> $2.99View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Rodman & RenshawReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Maxim GroupReiterated RatingBuy$36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Chardan CapitalReiterated RatingBuy$12.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2015HC WainwrightLower Price TargetBuy$25.20 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015RBC CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015Cantor FitzgeraldReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Ascendiant Capital MarketsReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2014Brinson PatrickInitiated CoverageOutperform$84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha